Immunotherapy and hyperprogression: Unwanted outcomes, unclear mechanism Journal Article

   


Authors: Knorr, D. A.; Ravetch, J. V.
Article Title: Immunotherapy and hyperprogression: Unwanted outcomes, unclear mechanism
Abstract: Hyperprogression(HP)isarecentlydefinedclinicalphenom-enon in which patients treated with immunotherapy paradoxically exhibit rapid tumor growth. The mechanisms of hyperprogression remain ill-defined, although recent studies in this issue point to a possible role for Fc receptors in this process. © 2018 American Association for Cancer Research.
Journal Title: Clinical Cancer Research
Volume: 25
Issue: 3
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2019-02-01
Start Page: 904
End Page: 906
Language: English
DOI: 10.1158/1078-0432.Ccr-18-3144
PUBMED: 30397179
PROVIDER: scopus
PMCID: PMC6359946
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060912130&doi=10.1158%2f1078-0432.CCR-18-3144&partnerID=40&md5=bff3745e136267f8a1924b931eaae951
Notes: Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. David A Knorr
    22 Knorr
Related MSK Work